126 related articles for article (PubMed ID: 27928649)
1. The Diagnostic Value of (1 → 3)-Beta-D-glucans and Galactomannan Assays in Children Suffering from Bacteremia in Pediatric Intensive Care Unit.
Zheng F; Gu Y; Zha H; Deng J; Zhang Z
Mycopathologia; 2017 Jun; 182(5-6):555-560. PubMed ID: 27928649
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic Values and Limitations of (1,3)-β-D-Glucans and Galactomannan Assays for Invasive Fungal Infection in Patients Admitted to Pediatric Intensive Care Unit.
Zheng F; Zha H; Yang D; Deng J; Zhang Z
Mycopathologia; 2017 Apr; 182(3-4):331-338. PubMed ID: 27664106
[TBL] [Abstract][Full Text] [Related]
3. Use and limits of (1-3)-β-d-glucan assay (Fungitell), compared to galactomannan determination (Platelia Aspergillus), for diagnosis of invasive aspergillosis.
Sulahian A; Porcher R; Bergeron A; Touratier S; Raffoux E; Menotti J; Derouin F; Ribaud P
J Clin Microbiol; 2014 Jul; 52(7):2328-33. PubMed ID: 24740084
[TBL] [Abstract][Full Text] [Related]
4. (1, 3)-β-D-glucan assay for diagnosing invasive fungal infections in critically ill patients with hematological malignancies.
Azoulay E; Guigue N; Darmon M; Mokart D; Lemiale V; Kouatchet A; Mayaux J; Vincent F; Nyunga M; Bruneel F; Rabbat A; Bretagne S; Lebert C; Meert AP; Benoit D; Pene F
Oncotarget; 2016 Apr; 7(16):21484-95. PubMed ID: 26910891
[TBL] [Abstract][Full Text] [Related]
5. [The significance of serum GM and BG antigens assay for invasive fungal infections in hematological malignancies patients].
Zeng SY; Liu T; Meng WT; Chen YN
Zhonghua Xue Ye Xue Za Zhi; 2011 Jan; 32(1):43-6. PubMed ID: 21429401
[TBL] [Abstract][Full Text] [Related]
6. Comparative evaluation of pan-fungal real-time PCR, galactomannan and (1-3)-β-D-glucan assay for invasive fungal infection in paediatric cancer patients.
Gupta P; Ahmad A; Khare V; Kumar A; Banerjee G; Verma N; Singh M
Mycoses; 2017 Apr; 60(4):234-240. PubMed ID: 27862370
[TBL] [Abstract][Full Text] [Related]
7. Comparative accuracy of 1,3 beta-D glucan and galactomannan for diagnosis of invasive fungal infections in pediatric patients: a systematic review with meta-analysis.
Singh S; Singh M; Verma N; Sharma M; Pradhan P; Chauhan A; Jaiswal N; Chakrabarti A; Singh M
Med Mycol; 2021 Feb; 59(2):139-148. PubMed ID: 32448907
[TBL] [Abstract][Full Text] [Related]
8. Disseminated aspergillosis following resolution of Pneumocystis pneumonia with sustained elevation of beta-glucan in an Intensive Care Unit: a case report.
Saito T; Shime N; Itoh K; Fujita N; Saito Y; Shinozaki M; Shibuya K; Makimura K; Hashimoto S
Infection; 2009 Dec; 37(6):547-50. PubMed ID: 19730788
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of biomarkers: Galactomannan and 1,3-beta-D-glucan assay for the diagnosis of invasive fungal infections in immunocompromised patients from a tertiary care centre.
Singh S; Kaur H; Choudhary H; Sethi S; Malhotra P; Gupta KL; Rudramurthy SM; Chakrabarti A
Indian J Med Microbiol; 2018; 36(4):557-563. PubMed ID: 30880706
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of serum (1 → 3)-β-D-glucan clinical performance: kinetic assessment, comparison with galactomannan and evaluation of confounding factors.
Pini P; Bettua C; Orsi CF; Venturelli C; Forghieri F; Bigliardi S; Faglioni L; Luppi F; Serio L; Codeluppi M; Luppi M; Mussini C; Girardis M; Blasi E
Infection; 2016 Apr; 44(2):223-33. PubMed ID: 26475482
[TBL] [Abstract][Full Text] [Related]
11. Prospective evaluation of a combination of fungal biomarkers for the diagnosis of invasive fungal disease in high-risk haematology patients.
Hammarström H; Stjärne Aspelund A; Christensson B; Heußel CP; Isaksson J; Kondori N; Larsson L; Markowicz P; Richter J; Wennerås C; Friman V
Mycoses; 2018 Sep; 61(9):623-632. PubMed ID: 29577474
[TBL] [Abstract][Full Text] [Related]
12. Clinical utility of fungal screening assays in adults with severe burns.
Blyth DM; Chung KK; Cancio LC; King BT; Murray CK
Burns; 2013 May; 39(3):413-9. PubMed ID: 22999208
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic accuracy of the 1,3-β-D-glucan test for pneumocystis pneumonia in a tertiary university hospital in Denmark: A retrospective study.
Engsbro AL; Najat S; Jørgensen KM; Kurtzhals JAL; Arendrup MC
Med Mycol; 2019 Aug; 57(6):710-717. PubMed ID: 30535059
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of invasive fungal diseases in pediatric patients.
Pana ZD; Vikelouda K; Roilides E
Expert Rev Anti Infect Ther; 2016 Dec; 14(12):1203-1213. PubMed ID: 27681004
[TBL] [Abstract][Full Text] [Related]
15. Performance Characteristics of Galactomannan and β-d-Glucan in High-Risk Liver Transplant Recipients.
Singh N; Winston DJ; Limaye AP; Pelletier S; Safdar N; Morris MI; Meneses K; Busuttil RW; Wagener MM; Wheat LJ
Transplantation; 2015 Dec; 99(12):2543-50. PubMed ID: 26050015
[TBL] [Abstract][Full Text] [Related]
16. Galactomannan, β-D-Glucan, and Polymerase Chain Reaction-Based Assays for the Diagnosis of Invasive Fungal Disease in Pediatric Cancer and Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.
Lehrnbecher T; Robinson PD; Fisher BT; Castagnola E; Groll AH; Steinbach WJ; Zaoutis TE; Negeri ZF; Beyene J; Phillips B; Sung L
Clin Infect Dis; 2016 Nov; 63(10):1340-1348. PubMed ID: 27567122
[TBL] [Abstract][Full Text] [Related]
17. Contribution of (1->3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan.
Pazos C; Pontón J; Del Palacio A
J Clin Microbiol; 2005 Jan; 43(1):299-305. PubMed ID: 15634986
[TBL] [Abstract][Full Text] [Related]
18. The interaction between piperacillin/tazobactam and assays for Aspergillus galactomannan and 1,3-beta-D-glucan in patients without risk factors for invasive fungal infections.
Metan G; Ağkuş C; Buldu H; Koç AN
Infection; 2010 Jun; 38(3):217-21. PubMed ID: 20237947
[TBL] [Abstract][Full Text] [Related]
19. Retrospective assessment of β-D-(1,3)-glucan for presumptive diagnosis of fungal infections.
Bellanger AP; Grenouillet F; Henon T; Skana F; Legrand F; Deconinck E; Millon L
APMIS; 2011 Apr; 119(4-5):280-6. PubMed ID: 21492228
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of micafungin as an empirical therapy for invasive fungal infections in patients with hematologic disorders: a multicenter, prospective study.
Yamaguchi M; Kurokawa T; Ishiyama K; Aoki G; Ueda M; Matano S; Takami A; Yamazaki H; Sawazaki A; Yamauchi H; Yoshida T; Nakao S
Ann Hematol; 2011 Oct; 90(10):1209-17. PubMed ID: 21695388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
